Sign Up to like & get recommendations! 0
Published in 2019 at "Digestive Diseases and Sciences"
DOI: 10.1007/s10620-019-05812-2
Abstract: Background and Aims Endoscopic papillectomy is a safe and effective treatment for ampullary adenomas and has mostly replaced surgical local resection. Recent data have discussed the role of endoscopic removal of laterally spreading adenomas associated… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Gastrointestinal endoscopy"
DOI: 10.1016/j.gie.2018.04.2332
Abstract: BACKGROUND AND AIMS Endobiliary dysplasia may persist after endoscopic papillectomy. Intraductal radiofrequency ablation (ID-RFA) is a potential alternative to complementary surgery. The aim of this study was to evaluate the efficacy and safety of ID-RFA… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Endoscopy"
DOI: 10.1055/a-1173-8418
Abstract: A 70-year-old asymptomatic woman underwent screening esophagogastroduodenoscopy, which revealed a bulging minor duodenal papilla with redness and rough surface (▶Fig. 1 a – c). Biopsy was suggestive of adenocarcinoma. Laboratory data included normal blood counts… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Endoscopy"
DOI: 10.1055/a-1948-1931
Abstract: Endoscopic papillectomy has been recommended by the European Society of Gastrointestinal Endoscopy for the treatment of ampullary adenomas without intraductal extension [1]; however, it is a challenging procedure that is associated with serious adverse events… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Scandinavian Journal of Gastroenterology"
DOI: 10.1080/00365521.2022.2085058
Abstract: Abstract Background Endoscopic papillectomy (EP) is an effective treatment for ampullary lesions but technically challenging because of anatomical specificities concerning the high rate of adverse events. Bleeding is one of the most feared complications and… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Scandinavian Journal of Gastroenterology"
DOI: 10.1080/00365521.2022.2088243
Abstract: Abstract Background This study aimed to compare post-operative morbidity, mortality, and completeness of resection following endoscopic vs. radical surgical resection for ampullary lesions. Methods A retrospective analysis of the prospectively collected data from a surgical… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Digestive Endoscopy"
DOI: 10.1111/den.13468
Abstract: Endoscopic papillectomy is increasingly being used for ampullary adenoma treatment. However, it remains challenging despite increased safety with treatment advances. The ideal power output and electrosurgical current mode for mucosal resection are not established. We… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Journal of Gastroenterology and Hepatology"
DOI: 10.1111/jgh.14922
Abstract: The usefulness of preventive closure of the frenulum after endoscopic papillectomy (EP) could reduce bleeding. The feasibility and safety of clipping were evaluated in this prospective pilot study. read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "United European Gastroenterology Journal"
DOI: 10.1177/2050640619868367
Abstract: Endoscopic papillectomy (EP) is a viable therapy in ampullary lesions (AL). Many series have reported low morbidity and acceptable outcomes. We performed a systematic review with pooled analysis to assess the safety and efficacy of… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Therapeutics and Clinical Risk Management"
DOI: 10.2147/tcrm.s309103
Abstract: Purpose Endoscopic papillectomy (EP) has been accepted as a viable alternative therapy to surgery in benign duodenal papillary lesions. However, postoperative complications limit its widespread clinical application. This study aimed to evaluate the overall safety… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Frontiers in Medicine"
DOI: 10.3389/fmed.2020.00152
Abstract: Background: Lesions of the Ampulla of Vater are a rare condition and represent 18 years of age) who underwent SA or PD for ampullary neoplasm between 2004 and 2018 or EP between 2007 and 2018… read more here.